| Trial ID: | L6317 |
| Source ID: | NCT00776607
|
| Associated Drug: |
Novomix 30
|
| Title: |
Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)
|
| Acronym: |
LIT
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Latent Autoimmune Diabetes in Adults LADA
|
| Interventions: |
DRUG: NovoMix 30|DRUG: Tablet treatment
|
| Outcome Measures: |
Primary: Change in fasting serum C-peptide level over 24 months and (2) change in HbA1c level over 24 months in patients with LADA., 24 months | Secondary: Hypoglycaemic events, 24 months
|
| Sponsor/Collaborators: |
Sponsor: Abertawe Bro Morgannwg University NHS Trust | Collaborators: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
200
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-04
|
| Completion Date: |
2011-04
|
| Results First Posted: |
|
| Last Update Posted: |
2008-10-21
|
| Locations: |
Diabetes Unit, Cardiff, Wales, CF64 2XX, United Kingdom|Clinical Research Unit, Swansea, Wales, SA6 6NL, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT00776607
|
